2
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Esophageal Neoplasms
5
Barrett Esophagus
3
Pancreatic Neoplasms
2
Neoplasms
2
Lung Neoplasms
2
Stomach Neoplasms
1
Liver Neoplasms
1
Liver Cirrhosis
1
Fibrosis
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breath Test
1
Breast Neoplasms
1
Adenocarcinoma Of Esophagus
1
Interventions
Fluorouracil
67
Radiotherapy
53
Cisplatin
52
Oxaliplatin
47
Leucovorin
37
Paclitaxel
36
Irinotecan
27
Docetaxel
23
Capecitabine
20
Nivolumab
17
Carboplatin
16
pembrolizumab
15
Radiation
15
Neoadjuvant Therapy
15
Surgical Procedures, Operative
12
Cetuximab
12
durvalumab
9
Drug Therapy
9
Biopsy
9
Taxes
8
Folfox protocol
8
Chemotherapy, Adjuvant
8
Trastuzumab
7
Magnetic Resonance Spectroscopy
7
Gefitinib
7
Endoscopy
7
tremelimumab
6
Specimen Handling
6
Endoscopy, Digestive System
6
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Breath Tests
×
Clear all
NCT07260734
2025-12-03
AROMA2
Imperial College London
Not yet recruiting
6,000 enrolled